GSK plc GSK
NYSE GSK
$47.83 -0.75 (-1.54%)
At close: Nov 19, 2026 · 4:00 PM EST

Gsk (GSK) Retained Earnings (2009 - 2026)

Updated

Gsk (GSK) recorded Retained Earnings of $16.49 billion in the quarter ended Sep 30, 2026, up 22.5% from $13.46 billion a year earlier and up 8.5% from the prior quarter.

Analysis

Gsk (GSK) Retained Earnings (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk reported Retained Earnings of $13.75 billion, up 40.5% from the prior year.

  • Annual Retained Earnings has increased for three straight years, with a five-year compound annual growth rate of 8.3% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Retained Earnings came in at $9.78 billion in the year ended Dec 31, 2024 (+6.1%), $9.22 billion in the year ended Dec 31, 2023 (+75.2%), $5.26 billion in the year ended Dec 31, 2022 (-50.9%) and $10.72 billion in the year ended Dec 31, 2021 (+16.5%).
  • The figure for the quarter ended Sep 30, 2026 is the highest quarterly Retained Earnings in data going back to the quarter ended Mar 31, 2009.
  • On a year-over-year basis, Retained Earnings has increased for 13 consecutive quarters, with growth averaging 22.3% over the last eight quarters.
  • Peak year-over-year performance for Retained Earnings in the last five years was growth of 195.8% in the quarter ended Sep 30, 2023, against a decline of 72.3% in the quarter ended Sep 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $15.19 billion (quarter ended Jun 30, 2026), $15.27 billion (quarter ended Mar 31, 2026) and $13.75 billion (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -105.12 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 37.97 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 168.36 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -16.19 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 66.22 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -19.81 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 3.11 Bn
9 Gsk 193.54 Bn 176.38 Bn - 16.49 Bn
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn 115.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.49 Bn
Jun 30, 2026 15.19 Bn
Mar 31, 2026 15.27 Bn
Dec 31, 2025 13.75 Bn
Sep 30, 2025 13.46 Bn
Jun 30, 2025 12.07 Bn
Mar 31, 2025 10.75 Bn
Dec 31, 2024 9.78 Bn
Sep 30, 2024 10.96 Bn
Jun 30, 2024 10.85 Bn
Mar 31, 2024 10.02 Bn
Dec 31, 2023 9.22 Bn
Sep 30, 2023 8.56 Bn
Jun 30, 2023 8.10 Bn
Mar 31, 2023 7.01 Bn
Dec 31, 2022 5.26 Bn
Sep 30, 2022 2.90 Bn
Jun 30, 2022 11.92 Bn
Mar 31, 2022 12.66 Bn
Dec 31, 2021 10.72 Bn
API Access

Gsk Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=GSK&period=max&api_key=YOUR_API_KEY